QuantRx Biomedical (QTXB) Stock Price, News & Analysis

Company Overview

QuantRx Biomedical Corporation engages in the development and commercialization of patented miniform pads (PADs) and PAD based over-the-counter products in the United States. It is also developing genomic diagnostics for the laboratory market based on its lateral flow patents, including RapidSense technology, a one-step lateral flow test. The company's PAD products are used for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. Its products include InSync, a feminine hygienic interlabial pad; Unique miniform, a treated pad for the temporary relief of the itch and discomfort associated with hemorrhoids and minor vaginal infection, as well as an untreated pad for the daily protection of light urinary, vaginal, or anal leakage; and other treated miniform products. QuantRx Biomedical Corporation was incorporated in 1986 and is based in Tualatin, Oregon.

Key Stats

• Today's Range: $0.0005 to $0.0005
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.0015
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $39,350.00
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

QTXB Stock Analysis - Frequently Asked Questions

How have QTXB shares performed this year?

QuantRx Biomedical's stock was trading at $0.0005 at the beginning of the year. Since then, QTXB shares have increased by 0.0% and is now trading at $0.0005.
View the best growth stocks for 2025 here.

How do I buy shares of QuantRx Biomedical?

Shares of QTXB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of QuantRx Biomedical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that QuantRx Biomedical investors own include Augusta Gold (AUGG), Auxly Cannabis Group (CBWTF), Christopher & Banks (CBK), Babcock & Wilcox Enterprises (BW), Ascent Solar Technologies (ASTI), Arch Therapeutics (ARTH) and Amerigo Resources (ARREF).

Company Calendar

• Today: 3/28/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Surgical & medical instruments
• Sub-Industry: Medical Equipment
• Current Symbol: OTCMKTS:QTXB
• CIK: 820608
• Web: www.quantrx.com
• Phone: (212) 980-2235
• Fax: 1-267-880-1596
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 78,700,000
• Free Float: N/A
• Market Cap: $39,350.00
• Optionable: Not Optionable
• Beta: -4.30